PMC:7200337 / 32773-32943
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T334","span":{"begin":120,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A334","pred":"fma_id","subj":"T334","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes (Giamarellos-Bourboulis et al., 2020)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T151","span":{"begin":35,"end":37},"obj":"Chemical"},{"id":"T153","span":{"begin":49,"end":59},"obj":"Chemical"},{"id":"T154","span":{"begin":60,"end":71},"obj":"Chemical"}],"attributes":[{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A152","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A153","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A154","pred":"chebi_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes (Giamarellos-Bourboulis et al., 2020)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1071","span":{"begin":82,"end":84},"obj":"Gene"},{"id":"1083","span":{"begin":60,"end":71},"obj":"Chemical"}],"attributes":[{"id":"A1071","pred":"tao:has_database_id","subj":"1071","obj":"Gene:6999"},{"id":"A1083","pred":"tao:has_database_id","subj":"1083","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes (Giamarellos-Bourboulis et al., 2020)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T183","span":{"begin":0,"end":170},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes (Giamarellos-Bourboulis et al., 2020)."}